Division of Nephrology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Nephrol Dial Transplant. 2010 Aug;25(8):2616-24. doi: 10.1093/ndt/gfq308. Epub 2010 Jun 2.
Glomerular filtration rate (GFR) and co-morbidity at dialysis initiation in relation to mortality in end-stage renal disease is still controversial. We studied factors potentially related to the mortality in incident haemodialysis (HD) patients.
A national database included 23 551 incident HD patients from July 2001 to December 2004. Kaplan-Meier and Cox regression analyses were performed to assess the association between GFR estimated by the four-variable Modified Diet in Renal Disease equation and all-cause mortality. Analyses were performed from Day 91 after the start of dialysis. Patients were classified into five groups (quintiles) based on estimated glomerular filtration rate (eGFR) at the start of dialysis.
The median eGFR at dialysis initiation was low (4.7 mL/min/1.73 m(2)), as was the mortality in the first year of dialysis [13.2/100 patient-year, 95% confidence interval (95% CI) = 12.8-13.7]. There was an inverse association between lower eGFR and higher survival rate. The Cox regression model revealed an increase in mortality risk in Q5 (hazard ratio [HR] = 2.44, 95% CI = 2.11-2.81), Q4 (HR = 1.66, 95% CI = 1.43-1.93), Q3 (HR = 1.21, 95% CI = 1.04-1.41) and Q2 (HR = 1.18, 95% CI = 1.01-1.37) compared with the reference group of Q1 after adjusting for year of application, primary diseases (chronic glomerulonephritis, diabetic nephropathy, hypertension, chronic tubulointerstitial nephritis and others), demographics (age, sex), presence of co-morbidity (diabetes mellitus, hypertension, congestive heart failure, ischaemic heart diseases, cerebrovascular diseases, malignancies, liver cirrhosis, tuberculosis, other diseases and free of reported of co-morbidities) and haematocrit. Propensity score analysis also showed a higher eGFR to be associated with increased mortality risks. Adjustment for all covariates explained a high percentage of excess risk of mortality in the groups with low eGFR, but less risk in the groups with higher eGFR.
Lower eGFR at dialysis initiation is associated with lower mortality. Conditions at dialysis initiation explained excess 1-year mortality risk differently in patients who began dialysis at different levels of eGFR. Other factors likely contribute to the mortality of patients initiating dialysis at higher eGFR levels, and further study is needed.
在开始透析时肾小球滤过率(GFR)和合并症与终末期肾病的死亡率之间的关系仍存在争议。我们研究了与新发生血液透析(HD)患者死亡率相关的潜在因素。
一项全国性数据库纳入了 2001 年 7 月至 2004 年 12 月期间的 23551 例新发生的 HD 患者。采用 Kaplan-Meier 和 Cox 回归分析评估由四变量改良肾脏病饮食公式估算的 GFR 与全因死亡率之间的关系。分析从透析开始后的第 91 天开始进行。根据透析开始时的估计肾小球滤过率(eGFR)将患者分为五组(五分位组)。
透析开始时的中位 eGFR 较低(4.7 mL/min/1.73 m2),透析第一年的死亡率也较高[13.2/100 患者年,95%置信区间(95%CI)=12.8-13.7]。较低的 eGFR 与较高的生存率呈负相关。Cox 回归模型显示,第 5 组(危险比[HR] = 2.44,95%CI = 2.11-2.81)、第 4 组(HR = 1.66,95%CI = 1.43-1.93)、第 3 组(HR = 1.21,95%CI = 1.04-1.41)和第 2 组(HR = 1.18,95%CI = 1.01-1.37)的死亡率风险较第 1 组参考组增加,校正应用年份、原发性疾病(慢性肾小球肾炎、糖尿病肾病、高血压、慢性肾小管间质性肾炎和其他疾病)、人口统计学因素(年龄、性别)、合并症(糖尿病、高血压、充血性心力衰竭、缺血性心脏病、脑血管疾病、恶性肿瘤、肝硬化、结核病、其他疾病和无合并症报告)和血细胞比容后。倾向评分分析也表明,较高的 eGFR 与死亡率风险增加相关。调整所有协变量可以解释 eGFR 较低组的死亡率过高风险,但 eGFR 较高组的风险较低。
透析开始时较低的 eGFR 与较低的死亡率相关。在开始透析时的不同 eGFR 水平的患者中,不同的条件解释了额外的 1 年死亡率风险。其他因素可能导致 eGFR 水平较高的患者开始透析后的死亡率增加,需要进一步研究。